Skip to main content
Erschienen in: Cancer Causes & Control 6/2007

01.08.2007 | Original Paper

Birthweight by gestational age and childhood cancer

verfasst von: Joachim Schüz, Michele R. Forman

Erschienen in: Cancer Causes & Control | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

The objective of this research was to compare the association of birthweight alone with gender-specific birthweight-for-gestational age on childhood cancer risk in a large population-based case–control study in Germany. Incident cases of childhood cancer (n = 2,024, diagnosed 1992–1994) were ascertained from the German Childhood Cancer Registry. Controls were randomly drawn from population registries. Parents reported risk factor information in a mailed questionnaire and telephone interview. The odds ratio for acute lymphoblastic leukemia (ALL) was 1.41 (95% confidence interval 1.08–1.84) in the high-birthweight category (>4 kg) and was 1.45 (1.07–1.97) in the large-for-gestational age (LGA) category compared to the normal birthweight (2.5–4 kg) and the appropriate-for-gestational age (AGA) categories, respectively. However, the agreement between the birthweight and birthweight-for-gestational age was only moderate. Subgroup analyses revealed elevated odds ratios for ALL and CNS tumors in first born’s who were LGA but of normal birth weight. Thus, two findings from this post-hoc analysis are worthy of note: (1) the use of birthweight-for-gestation age categories within birthweight sub-groups potentially identified new high-risk groups among firstborns for ALL tumors and among all children for CNS tumors; and (2) although the magnitudes of risk estimators for ALL were comparable in the traditional high-birthweight group and in the LGA, the same children were not jointly classified in the same newborn categories indicating two potentially different subsets of children at risk.
Literatur
1.
Zurück zum Zitat Little J (1990) Epidemiology of childhood cancer. IARC Scientific Publications No149. Lyon, France Little J (1990) Epidemiology of childhood cancer. IARC Scientific Publications No149. Lyon, France
2.
Zurück zum Zitat Ross JA, Perentesis JP, Robison LL, Davies SM (1997) Big babies and infant leukemia: a role for insulin-like growth factor-1? Cancer Causes Control 7:553–559CrossRef Ross JA, Perentesis JP, Robison LL, Davies SM (1997) Big babies and infant leukemia: a role for insulin-like growth factor-1? Cancer Causes Control 7:553–559CrossRef
3.
Zurück zum Zitat Hjalgrim LL, Rostgaard K, Hjalgrim H et al (2004) Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland. J Natl Cancer Inst 96:1549–1556PubMedCrossRef Hjalgrim LL, Rostgaard K, Hjalgrim H et al (2004) Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland. J Natl Cancer Inst 96:1549–1556PubMedCrossRef
4.
Zurück zum Zitat Hjalgrim LL, Westergaard T, Rostgaard K et al (2003) Birthweight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemol 158:724–735CrossRef Hjalgrim LL, Westergaard T, Rostgaard K et al (2003) Birthweight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemol 158:724–735CrossRef
5.
Zurück zum Zitat Schüz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J (2001) High birthweight and other risk factors for Wilms’ tumour: results of a population-based case-control study. Eur J Pediatr 160:333–338PubMedCrossRef Schüz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J (2001) High birthweight and other risk factors for Wilms’ tumour: results of a population-based case-control study. Eur J Pediatr 160:333–338PubMedCrossRef
6.
Zurück zum Zitat von Behren J, Reynolds P (2003) Birth characteristics and brain cancers in young children. Int J Epidemiol 32:248–256CrossRef von Behren J, Reynolds P (2003) Birth characteristics and brain cancers in young children. Int J Epidemiol 32:248–256CrossRef
7.
Zurück zum Zitat Grassi AE, Giuliano MA (2000) The neonate with macrosomia. Clin Obstetr Gynecol 43:340–348CrossRef Grassi AE, Giuliano MA (2000) The neonate with macrosomia. Clin Obstetr Gynecol 43:340–348CrossRef
8.
Zurück zum Zitat Godfrey KM (2001) The ‘Gold Standard’ for optimal fetal growth and development. J Pedatri Endocrinol Metab 14:1507–1514 Godfrey KM (2001) The ‘Gold Standard’ for optimal fetal growth and development. J Pedatri Endocrinol Metab 14:1507–1514
9.
Zurück zum Zitat Kramer MS, Morin I, Yang H et al (2002) Why are babies getting bigger? Temporal trends in fetal growth and its determinants. J Pediatr 141:538–542PubMedCrossRef Kramer MS, Morin I, Yang H et al (2002) Why are babies getting bigger? Temporal trends in fetal growth and its determinants. J Pediatr 141:538–542PubMedCrossRef
10.
Zurück zum Zitat Ventura SJ, Hamilton BE, Mathews TJ, Chandra A (2003) Trends and variations in smoking during pregnancy and low birth weight: evidence from the birth certificate, 1990–2000. Pediatrics 111:1176–1180PubMed Ventura SJ, Hamilton BE, Mathews TJ, Chandra A (2003) Trends and variations in smoking during pregnancy and low birth weight: evidence from the birth certificate, 1990–2000. Pediatrics 111:1176–1180PubMed
11.
Zurück zum Zitat Yerushalmy J (1967) The classification of newborn infants by birth weight and gestational age. J Pediatr 71:164–172PubMedCrossRef Yerushalmy J (1967) The classification of newborn infants by birth weight and gestational age. J Pediatr 71:164–172PubMedCrossRef
12.
Zurück zum Zitat Schüz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28:631–639PubMedCrossRef Schüz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28:631–639PubMedCrossRef
13.
Zurück zum Zitat Kaatsch P, Haaf G, Michaelis J (1995) Childhood malignancies in Germany- methods and results of a nationwide registry. Eur J Cancer 31A:993–999PubMedCrossRef Kaatsch P, Haaf G, Michaelis J (1995) Childhood malignancies in Germany- methods and results of a nationwide registry. Eur J Cancer 31A:993–999PubMedCrossRef
14.
Zurück zum Zitat Voigt M, Schneider KTM, Jährig K (1996) Analyse des Geburtengutes des Jahrgangs 1992 der Bundesrepublik Deutschland [Analysis of the total number of births in 1992 in the Federal Republic of Germany] (in German). Geburtshilfe Frauenheilkd 56:550–558PubMed Voigt M, Schneider KTM, Jährig K (1996) Analyse des Geburtengutes des Jahrgangs 1992 der Bundesrepublik Deutschland [Analysis of the total number of births in 1992 in the Federal Republic of Germany] (in German). Geburtshilfe Frauenheilkd 56:550–558PubMed
15.
Zurück zum Zitat Voigt M, Schneider KTM, Friese K, Hesse V, Jährig K (1999) Analyse des Geburtengutes der Bundesrepublik Deutschland. Teil 3: Perzentilwerte für das Geburtsgewicht, die Geburtslänge und den Kopfumfang deutscher Zwillinge (in German). Geburtshilfe Frauenheilkd 59:346–354CrossRef Voigt M, Schneider KTM, Friese K, Hesse V, Jährig K (1999) Analyse des Geburtengutes der Bundesrepublik Deutschland. Teil 3: Perzentilwerte für das Geburtsgewicht, die Geburtslänge und den Kopfumfang deutscher Zwillinge (in German). Geburtshilfe Frauenheilkd 59:346–354CrossRef
16.
Zurück zum Zitat Stokes ME, Davis CS, Koch GG (1995) Categorical data analysis using the SAS System. SAS Institute Inc., Cary, NC, USA Stokes ME, Davis CS, Koch GG (1995) Categorical data analysis using the SAS System. SAS Institute Inc., Cary, NC, USA
17.
Zurück zum Zitat Brookmeyer R, Liang KY, Linet M (1986) Matched case-control designs and overmatched analyses. Am J Epidemiol 124:693–701PubMed Brookmeyer R, Liang KY, Linet M (1986) Matched case-control designs and overmatched analyses. Am J Epidemiol 124:693–701PubMed
18.
Zurück zum Zitat Landis JR, Koch GG (1997) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef Landis JR, Koch GG (1997) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef
19.
Zurück zum Zitat Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE (1986) Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 76:1035–1039PubMed Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE (1986) Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 76:1035–1039PubMed
20.
Zurück zum Zitat Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE (1986) Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 76:1035–1039PubMed Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE (1986) Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 76:1035–1039PubMed
21.
Zurück zum Zitat Yu H, Rohan T (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92:1472–1489PubMedCrossRef Yu H, Rohan T (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92:1472–1489PubMedCrossRef
22.
Zurück zum Zitat Lof M, Olausson H, Bostrom K, Janerot-Sjoberg B, Sohlstrom A, Forsum E (2005) Changes in basal metabolic rate during pregnancy in relation to changes in body weight and composition, cardiac output, insulin-like growth factor I, and thyroid hormones and in relation to fetal growth. Am J Clin Nutr 81:678–685PubMed Lof M, Olausson H, Bostrom K, Janerot-Sjoberg B, Sohlstrom A, Forsum E (2005) Changes in basal metabolic rate during pregnancy in relation to changes in body weight and composition, cardiac output, insulin-like growth factor I, and thyroid hormones and in relation to fetal growth. Am J Clin Nutr 81:678–685PubMed
23.
Zurück zum Zitat Chellakooty M, Vangsgaard K, Larsen T et al (2004) A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab 89:384–391PubMedCrossRef Chellakooty M, Vangsgaard K, Larsen T et al (2004) A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab 89:384–391PubMedCrossRef
25.
Zurück zum Zitat Castanon I, Baylies MK (2002) A Twist in fate: evolutionary comparison of Twist structure and function. Gene 287:11–22PubMedCrossRef Castanon I, Baylies MK (2002) A Twist in fate: evolutionary comparison of Twist structure and function. Gene 287:11–22PubMedCrossRef
26.
Zurück zum Zitat Kang Y, Massague J (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118:277–279PubMedCrossRef Kang Y, Massague J (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118:277–279PubMedCrossRef
27.
Zurück zum Zitat Yang J, Mani SA, Donaher JL et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumour metastasis. Cell 117:927–939PubMedCrossRef Yang J, Mani SA, Donaher JL et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumour metastasis. Cell 117:927–939PubMedCrossRef
28.
Zurück zum Zitat Pajer P, Pecenka V, Karafiat V, Kralova J, Horejsi Z, Dvorak M (2003) The twist gene is a common target of retroviral integration and transcriptional deregulation in experimental nephroblastoma. Oncogene 22:665–673PubMedCrossRef Pajer P, Pecenka V, Karafiat V, Kralova J, Horejsi Z, Dvorak M (2003) The twist gene is a common target of retroviral integration and transcriptional deregulation in experimental nephroblastoma. Oncogene 22:665–673PubMedCrossRef
29.
Zurück zum Zitat Valsesia-Wittmann S, Magdeleine M, Dupasquier S et al (2004) Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 6:625–630PubMedCrossRef Valsesia-Wittmann S, Magdeleine M, Dupasquier S et al (2004) Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 6:625–630PubMedCrossRef
30.
Zurück zum Zitat Entz-Werle N, Stoetzel C, Berard-Marec P et al (2005) Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas. Int J Cancer May 117:349–355CrossRef Entz-Werle N, Stoetzel C, Berard-Marec P et al (2005) Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas. Int J Cancer May 117:349–355CrossRef
31.
Zurück zum Zitat Oram KF, Gridley T (2005) Mutations in snail family genes enhance craniosynostosis of Twist1 haplo-insufficient mice: implications for Saethre-Chotzen Syndrome. Genetics 170:971–974PubMedCrossRef Oram KF, Gridley T (2005) Mutations in snail family genes enhance craniosynostosis of Twist1 haplo-insufficient mice: implications for Saethre-Chotzen Syndrome. Genetics 170:971–974PubMedCrossRef
32.
Zurück zum Zitat de Heer IM, de Klein A, van den Ouweland AM et al (2005) Clinical and genetic analysis of patients with Saethre-Chotzen syndrome. Plast Reconstr Surg 115:1894–1902PubMedCrossRef de Heer IM, de Klein A, van den Ouweland AM et al (2005) Clinical and genetic analysis of patients with Saethre-Chotzen syndrome. Plast Reconstr Surg 115:1894–1902PubMedCrossRef
33.
Zurück zum Zitat Schüz J (2003) Non-response bias as a likely cause for the association between young maternal age at the time of delivery and the risk of cancer in the offspring. Paediatr Perinat Epidemiol 17:106–112PubMedCrossRef Schüz J (2003) Non-response bias as a likely cause for the association between young maternal age at the time of delivery and the risk of cancer in the offspring. Paediatr Perinat Epidemiol 17:106–112PubMedCrossRef
34.
Zurück zum Zitat Schüz J, Spector LF, Ross JA (2003) Bias in studies of parental self-reported occupational exposures and childhood cancer. Am J Epidemiol 158:710–716PubMedCrossRef Schüz J, Spector LF, Ross JA (2003) Bias in studies of parental self-reported occupational exposures and childhood cancer. Am J Epidemiol 158:710–716PubMedCrossRef
35.
Zurück zum Zitat Linet MS, Wacholder S, Zahm SH (2003) Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics 112:218–232PubMed Linet MS, Wacholder S, Zahm SH (2003) Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics 112:218–232PubMed
36.
Zurück zum Zitat von Kries R, Göbel U, Hachmeister A, Kaletsch U, Michaelis J (1996) Vitamin K and childhood cancer: a population based case-control study in Lower Saxony, Germany. BMJ 313:199–203 von Kries R, Göbel U, Hachmeister A, Kaletsch U, Michaelis J (1996) Vitamin K and childhood cancer: a population based case-control study in Lower Saxony, Germany. BMJ 313:199–203
37.
Zurück zum Zitat Kaatsch P, Kaletsch U, Meinert R et al (1998) German case control study on childhood leukemia–basic considerations, methodology and summary of the results. Klin Padiatr 210:185–191PubMedCrossRef Kaatsch P, Kaletsch U, Meinert R et al (1998) German case control study on childhood leukemia–basic considerations, methodology and summary of the results. Klin Padiatr 210:185–191PubMedCrossRef
38.
Zurück zum Zitat Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL (1997) Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children’s Cancer Group. Am J Epidemiol 145:58–67PubMed Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL (1997) Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children’s Cancer Group. Am J Epidemiol 145:58–67PubMed
39.
Zurück zum Zitat Queisser-Luft A, Stolz G, Wiesel A, Schlaefer K, Spranger J (2002) Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990–1998). Arch Gynecol Obstet 266:163–167PubMedCrossRef Queisser-Luft A, Stolz G, Wiesel A, Schlaefer K, Spranger J (2002) Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990–1998). Arch Gynecol Obstet 266:163–167PubMedCrossRef
Metadaten
Titel
Birthweight by gestational age and childhood cancer
verfasst von
Joachim Schüz
Michele R. Forman
Publikationsdatum
01.08.2007
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 6/2007
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-007-9011-y

Weitere Artikel der Ausgabe 6/2007

Cancer Causes & Control 6/2007 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.